Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis

Determination of the Efficacy of Different Medications for Idiopathic Rhinitis Clinical Trial

Official title: Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis

Status Recruiting

Clinical Trial Summary

Chronic rhinitis (CR) is one of the most common nasal mucosal diseases in the world. In China, about 140 million people suffer from this disease. Chronic rhinitis can lead to severe economic and social burden, as well as the potential risk of developing other chronic diseases such as asthma and chronic sinusitis. Therefore, it is of great significance to explore the classification and treatment strategies of chronic rhinitis in order to improve the health level of Chinese people.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Common Cold
• Determination of the Efficacy of Different Medications for Idiopathic Rhinitis
• Impact of Different Medications on Biomarkers of Idiopathic Rhinitis
• Rhinitis
• Safety and Tolerance of Different Medications for Idiopathic Rhinitis

• NCT number: NCT04002349
• Study type: Interventional
• Source: Beijing Tongren Hospital
• Status: Recruiting
• Phase: N/A
• Start date: July 1, 2019
• Completion date: March 31, 2020